Mark Gudgeon

Frimley Park Hospital

Papers

2

Total Citations

1,344

H-Index

2

About

Mark Gudgeon is a leading surgical researcher whose work has fundamentally shaped the landscape of minimally invasive colorectal surgery. His primary research areas center on robotic-assisted surgery, laparoscopic techniques, and oncological outcomes for rectal cancer. Gudgeon’s most significant contribution is his landmark 2017 study, which directly compared robotic-assisted to conventional laparoscopic surgery for rectal cancer resection. This pivotal trial, cited over 1,300 times, provided crucial evidence on the risk of conversion to open laparotomy, helping surgeons worldwide weigh the benefits and limitations of robotic platforms in complex pelvic procedures. Beyond this defining work, Gudgeon was instrumental in the ROLARR trial, the first worldwide randomized study of its kind, which set a new standard for evidence-based surgical practice. His research has not only informed clinical guidelines but also empowered surgeons with data-driven insights to optimize patient outcomes. Through his rigorous methodology and focus on real-world surgical challenges, Gudgeon has established himself as a key authority in the evolution of robotic colorectal surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
1,344
Total Citations
672
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer
1,341 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Frimley Park Hospital

Top Papers

  1. 1
  2. 2
    Short Term Pathology Results from the First World Wide Randomised Trial of Robotic Versus Laparoscopic Resection for Rectal Cancer (ROLARR)
    3 citations · 2016

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago